Cerevel Therapeutics Holdings, Inc.

Pharmaceutical Preparations·CAMBRIDGE, MA

Cerevel Therapeutics Holdings, Inc. was an American biotechnology and pharmaceuticals company based in Cambridge, Massachusetts, focused on the development of novel therapies for mental and neurological illnesses.

Financials

18 shown

Type	Period	Ended	Filed
10-Q	Q1 2024	3/31/24	5/8/24	→
10-K/A	FY 2023	12/31/23	4/26/24	→
10-K	FY 2023	12/31/23	2/27/24	→
10-Q	Q3 2023	9/30/23	11/1/23	→
10-Q	Q2 2023	6/30/23	8/2/23	→
10-K/A	FY 2022	12/31/22	5/19/23	→
↓

Earnings Releases (8-K)

14 shown

Filed	Period
11/1/23	Q4 FY2023	→
10/11/23	Q3 FY2023	→
8/2/23	Q3 FY2023	→
5/3/23	Q1 FY2023	→
2/22/23	Q1 FY2023	→
11/8/22	Q4 FY2022	→
↓

News (8-K)

32 shown

Filed	Type	Description
8/1/24	Delisting	Entry into a Material Definitive Agreement	→
2/16/24	Vote	Submission of Matters to a Vote of Security Holders	→
12/7/23	Agreement	Entry into a Material Definitive Agreement	→
10/12/23	Agreement	Entry into a Material Definitive Agreement	→
6/8/23	Vote	Submission of Matters to a Vote of Security Holders	→
5/10/23	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
8/1/24	S-8 POS	S-8 POS	→
8/1/24	S-8 POS	S-8 POS	→
8/1/24	S-8 POS	S-8 POS	→
10/12/23	424B5	424B5	→
10/11/23	424B5	424B5	→
4/28/23	ARS	ARS	→
↓

Filing History(448 filings)

TypeDateAccessionPeriodSize

15-12G

Aug 12, 2024

0001193125-24-19836315-12G

—

12.2 KB

EFFECT

Aug 5, 2024

9999999995-24-002401

—

1.9 KB

EFFECT

Aug 5, 2024

9999999995-24-002397

—

1.9 KB

EFFECT

Aug 5, 2024

9999999995-24-002395

—

1.9 KB

EFFECT

Aug 5, 2024

9999999995-24-002392

—

1.9 KB

Aug 5, 2024

0000078003-24-000169PRIMARY DOCUMENT

Aug 1, 2024

5.7 KB

SC 13D/A

Aug 5, 2024

0000078003-24-000168SC 13D/A CEREVEL THERAPEUTICS HOLDINGS 5

—

81.4 KB

Aug 5, 2024

0000950170-24-0909094

Aug 1, 2024

12.9 KB

Aug 5, 2024

0000950170-24-0909084

Aug 1, 2024

11.7 KB

Aug 5, 2024

0000950170-24-0909034

Aug 1, 2024

11.5 KB

Aug 5, 2024

0000950170-24-0908614

Aug 1, 2024

10.5 KB

Aug 5, 2024

0000950170-24-0908534

Aug 1, 2024

9.5 KB

Aug 5, 2024

0000950170-24-0908514

Aug 1, 2024

14.9 KB

Aug 5, 2024

0000950170-24-0908424

Aug 1, 2024

9.5 KB

Aug 5, 2024

0000950170-24-0908414

Aug 1, 2024

10.6 KB

Aug 5, 2024

0000950170-24-0908334

Aug 1, 2024

9.7 KB

Aug 5, 2024

0000950170-24-0908304

Aug 1, 2024

12.9 KB

SC 13D/A

Aug 5, 2024

0001193125-24-193966SC 13D/A

—

29.5 KB

Aug 5, 2024

0000950170-24-0908274

Aug 1, 2024

10.6 KB

Aug 5, 2024

0000950170-24-0908224

Aug 1, 2024

10.5 KB

Aug 5, 2024

0000950170-24-0908154

Aug 1, 2024

11.6 KB

Aug 5, 2024

0000950170-24-0908134

Aug 1, 2024

10.4 KB

Aug 5, 2024

0000950170-24-0908064

Aug 1, 2024

9.6 KB

Aug 5, 2024

0000950170-24-0908014

Aug 1, 2024

10.5 KB

Aug 5, 2024

0000950170-24-0907904

Aug 1, 2024

9.7 KB

25 filings shown

Filed	Form	Description
2/9/24	DEFA14A	DEFA14A	→
1/18/24	DEFM14A	DEFM14A	→
1/5/24	PREM14A	PREM14A	→
12/7/23	DEFA14A	DEFA14A	→
4/28/23	DEFA14A	DEFA14A	→
4/28/23	DEF 14A	DEF 14A	→
↓

Cerevel Therapeutics Holdings, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(448 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
8/5/24	4	PRIMARY DOCUMENT	→
8/5/24	SC 13D/A	SC 13D/A CEREVEL THERAPEUTICS HOLDINGS 5	→
8/5/24	4	4	→
8/5/24	4	4	→
8/5/24	4	4	→
8/5/24	4	4	→
↓

Filed	Form	Description
8/12/24	15-12G	15-12G	→
8/5/24	EFFECT	EFFECT	→
8/5/24	EFFECT	EFFECT	→
8/5/24	EFFECT	EFFECT	→
8/5/24	EFFECT	EFFECT	→
8/1/24	25-NSE	25-NSE	→
↓